Clinical Trial Update: Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders [Phase 2]

View source ↗

Summary

A Phase 2 prospective pilot trial evaluating the feasibility and safety of oral zinc in GNAO1-related disorders has completed, sponsored by Children's Universit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choreoathetosis
• Developmental Delay
• Developmental and Epileptic Encephalopathy 17
• Dystonia
• Epilepsy
• Gnao1-related Disorder
• Neurodevelopmental Disorder with Involuntary Movements

Drugs mentioned

• ZINC (Zinc chloride)

Snippet

Sponsor: Children's University Hospital Cologne, Germany | Conditions: GNAO1, Dystonia | Phase 2 | Status: COMPLETED